Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that is currently ranked as the sixth leading cause of death in the United States. Those affected by the disease experience symptoms including but not limited to mental decline, memory loss, confusion, difficulty with language, and behavioral and mood changes.  One of the hallmarks of AD is inflammation that occurs both centrally in the brain and in the periphery. While inflammation is the natural response to activation of our immune system and is critical for our survival, neuroinflammation is heavily associated with AD pathology. Two main cellular mediators involved with the inflammatory response are members of the glial cell family, microglial cells and astrocytes. When chronic inflammation is uncontrolled, it can lead to harmful cell and tissue damage. The continuous presence of damaged neurons results in the constant activation of microglia and astrocytes. This generates a neuroinflammatory environment which is thought to promote neurodegeneration. Another process commonly up regulated in the brains of aging individuals is that of oxidative stress, which plays a major role in age-related neurodegeneration and cognitive decline. The process can occur due to dysfunction of the antioxidant system, causing the accumulation of reactive oxygen species (ROS) in the brain. One of the primary biological markers of AD is the aggregation of Amyloid beta (Abeta). Abeta itself has been shown to act as a pro-inflammatory agent, promoting the activation of many inflammatory components. The accumulation of Abeta aggregates is thought to be exacerbated by essential biometal ions such as zinc and copper. Dr. Kayla Green’s lab in the TCU Chemistry Department has successfully created compounds that can simultaneously chelate metal ions and act as a powerful antioxidant. They have developed a family of compounds all consisting of N-heterocyclic amines that in turn, have the capacity to perform radical scavenging and metal ion capture. For the experimental design, BV2 neuronal cells were treated with either H202 or LPS for 16 hours. Following treatment, MTT assays were performed to measure cell viability. Once a treatment concentration was discovered that significantly decreased cell viability, varying concentrations of the N-heterocyclic amine were added to test for a recovery in overall cell viability.

Exploring the Effects of Early Life Stage Nitrate Exposure on Sexual Development and Adult Reproduction

Nitrate is a ubiquitous environmental contaminant that enters aquatic ecosystems as runoff from agricultural fertilizers, human and animal waste, and industrial processes. Previous animal studies indicate that at sublethal concentrations, nitrate acts as an anti-androgen in adult male vertebrates. However, a recent study using developing fathead minnows (Pimephales promelas) found that exposure to nitrate was correlated with increased androgen concentrations. This study sought to reconcile these conflicting results by exploring the impacts of environmentally realistic, early life stage nitrate exposure on male sexual development and adult reproduction. The main objective of this study was to identify the potential endocrine disrupting effects of nitrate across multiple levels of biological organization in male fathead minnows. Larvae less than 1 day post hatch were divided into three groups: 1) control, 2) low nitrate (50 mg/L NO3), 3) high nitrate (100 mg/L NO3) and exposed for 35 days. Gonadal gene expression of sex-steroid related genes was assessed in a subset of fish immediately following exposure. The remaining fish in each exposure group were raised in clean water until sexual maturity (115 dph) and then subjected to a 21-day breeding study, after which morphological measurements and male secondary sex characteristics were assessed. Gene expression analysis revealed that male fish in the high nitrate group had significantly decreased expression of a key enzyme in the sex steroid synthesis pathway than that of the control males. Breeding pairs in the high nitrate group also had a significant reduction in average clutch size. However, when these results are taken in conjunction with the analyses of the other target genes, breeding study endpoints, and morphological measurements, the exact effects of nitrate on the processes of sexual development and adult reproduction remain unclear.

Introduction: The purpose of this research was to determine differences in the effects of the sex hormone estrogen between the two genders on the endothelial function in vivo. Method: There was a total of forty-six college students from a liberal college in the South recruited. The forty-six students were twenty males and twenty-six females, who were divided into three groups: 20 males, 8 females (not taking any form of birth control) and 13 females (taking oral contraceptives). The participants were invited to complete a TCU approved IRB consent form and medical history questionnaire. Upon completion, the participants provided passive drool saliva for biomarker and sex hormone measurement and FMD for brachial artery flow and shear stress measurements. Results: Findings reveals that the mean age for males was 27.81 years and the mean age for females was 24.81 years. This data was found to be not significant (p = 0.0586). The BMI for males was 26.3 ± 3.59 kg/m2 and the BMI for females was 22.8 ± 2.36 kg/m2, found to be significant (p = 0.0003). 17-beta estradiol level was measured during follicular phase. There was no significant difference between men, women, and women on birth control. However, there was significant difference between male and female regarding nitrate production during the follicular phase (p = 0.0461). When comparing the post flow shear rate between women on birth control and women not on birth control, there was an increase in the shear velocity. Even though there was no significant change in sheer rate and FMD in the women on birth control, a trend toward an increase of both measures was noticed. Conclusion: There was found to be no significant difference in the effects of estrogen between men and women. Further research should be conducted to further specify the differences between women on contraceptives and men.

In partnership with UT Southwestern Moncrief Cancer Institute (MCI), the FWAYA Oncology Coalition, and TCU Pre-Health, our dedicated group of senior students at Texas Christian University aim to organize an awareness week for Adolescents and Young Adults (AYA) with cancer during the national AYA Cancer awareness week (3/31-4/6) of spring 2019 to reach students on campus. The Moncrief Cancer Institute has a leading AYA cancer program, offering individualized treatment, support, and therapy at no cost for patients who have been diagnosed with cancer. AYA oncology refers to the care and research focused on adolescents and young adults diagnosed with cancer, specifically those between the age of 15 to 39 years old. Every year 80,000 AYA’s are diagnosed with cancer in the U.S, and 600 of these patients are living in and around Tarrant County. The goal of our project is two-fold. First, we seek to raise awareness for programs and resources available to AYA patients with cancer through a campus campaign. As many members of the Texas Christian University identify between the ages of 15 and 39, we believe this cause is pertinent to TCU’s population. Second, we seek to connect the TCU community with events hosted in DFW by UT Southwestern Moncrief Cancer Institute and the FWAYA Oncology Coalition. TCU AYA Cancer Week 2019 is an Experiential
Projects that Impact the Community (EPIC) Grant project.

Hepatitis C is a disease of the liver that is caused by the Hepatitis C virus. The Hepatitis C virus (HCV) chronically infects between 130-170 million people in the world making it a significant health burden. HCV is 9.6 kb single-stranded RNA virus and a member of the Flaviviridae family of viruses which includes viruses such as Zika and Dengue. It is a smaller virus with a mature virion size between 50-80 nm. With a specific tropism for liver cells, the diseases of Hepatitis C are accordingly associated with the liver. The two predominant diseases related to HCV infection are cirrhosis and hepatocellular carcinoma. These are both caused as a result of chronic infection which occurs in about 80% of cases as opposed to acute infection which composes only 20% of cases. In order to establish a chronic infection the virus has evolved the ability to inhibit the innate immune response leading to a greater likelihood of reproduction and survival. Our specific interest was the mechanism by which HCV evades the host immune response. In previous studies we have shown that NS5A 10A, a mutant protein of NS5A, inhibits the activation of the IFN-β promoter which serves a key role in the innate immune response. In this paper we investigate the specific mechanism of the ability of NS5A 10A to interfere with the activation of the IFN-β promoter.